Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Kansas for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Kansas only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Kansas (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Blake Cooper (NPI 1275579567)

Field	Value
Entity Type	Individual
Organization	Blake Cooper
Address	8600 Quivira Rd Ste 100
City	Lenexa
State	KS
ZIP	66215
Taxonomy	Ophthalmology Physician
NPI Enumerated	June 22, 2006

Payer Source	Total Paid
Medicare	$2.4M
Medicaid	$0

Key Findings

This provider is effectively single-payer in the claims data: total Medicare revenue is $2.4M while there is no Medicaid billing on file, so payer exposure is concentrated in the Medicare population and the practice relies on Medicare for its recorded volumes and revenues. The absence of Medicaid billing on file limits conclusions about the provider's engagement with Medicaid patients and suggests payer mix risk if networks or reimbursement change.

Revenue is highly concentrated in a very small set of injection drugs: the top three Medicare codes by revenue account for 87.7% of this provider's total Medicare revenue, led by J2777 (68.6%) with J0178 (12.6%) and J2778 (6.4%) adding the bulk of the remainder. That concentration indicates the provider’s Medicare financial performance is driven overwhelmingly by a few high-cost injectable biologics.

The code mix and volumes indicate a retina-oriented, procedure-heavy practice: J2777 (57K claims) and other intravitreal injection codes (J0178, J2778) dominate revenue, while office E/M codes and routine visits (for example 99213 at $10.6K and 99214 at $10.5K, each 0.4% of Medicare revenue) contribute very small proportions. Procedural and drug reimbursement, rather than office visit E/M billing, appears to be the principal commercial activity recorded for Medicare.

For J2777 the provider is a high-volume national outlier: J2777 generates $1.7M (68.6% of Medicare revenue) and the provider ranks #76 of 2039 nationally (96th percentile; notably above typical national volume for this code), identifying the provider as a prominent national user of faricimab by Medicare claims. This high rank for a single drug code marks the provider as a major player in that specific therapeutic space compared with peers.

By contrast, the provider’s use of J0178 and J2778 is unremarkable relative to peers: J0178 produced $303.7K (12.6% of Medicare revenue) and ranks #2035 of 3204 providers nationally (36th percentile), while J2778 produced $154.8K (6.4% of Medicare revenue) and ranks #487 of 1208 providers nationally (60th percentile). These ranks show a mixed competitive position across different anti-VEGF products — dominant for J2777 but typical or modest for other agents.

Diagnostic imaging is another area of outsized activity: 92134 (2.3K claims, $63K, 2.6% of Medicare revenue) ranks #771 of 26868 providers nationally (97th percentile; extreme outlier, far above typical national volume for this code), indicating exceptionally high OCT imaging volume that complements the high injection throughput and supports a retina-focused workflow. High imaging volume suggests in-office diagnostic capacity that aligns with frequent procedural visits for injections.

The provider’s procedural ophthalmology codes beyond injections are present but not dominant: 67028 (1.2K claims, $103K, 4.3% of Medicare revenue) and 92235 (90 claims, $8.8K, 0.4%) show routine retina procedures and angiography support the injection-driven practice, while photography and ultrasound codes are relatively minor contributors. Together these patterns point to an operation organized around interventional retina care with ancillary diagnostic procedures.

The NPI was enumerated on 2006-06-22 (~20 years ago), indicating a long-tenured Medicare billing history; that longevity, combined with concentrated high-volume billing for J2777 and very high OCT use, is consistent with an established retina practice that has scaled specific procedural lines over time. However, the lack of any Medicaid billing on file means network access and patient-mix exposure are narrowly concentrated, which is important for payer negotiations and risk assessments.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

16 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J2777	Injection, faricimab‑svoa, 0.1 mg	57,010	$30	$1.7M
J0178	Injection, aflibercept, 1 mg	440	$690	$303.7K
J2778	Injection, ranibizumab, 0.1 mg	860	$180	$154.8K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,170	$90	$103K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	2,330	$30	$63K
92012	For this CPT code, an Ophthalmologist sees an established patient for an intermediate level eye examination. Generally, a patient is considered to be "established" if the same physician, or any…	560	$60	$32.7K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	340	$90	$29.5K
J3590	Unclassified biologics	90	$280	$24.5K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	200	$50	$10.6K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	130	$80	$10.5K

Showing 1–10 of 16

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 16 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Kansas Distribution

Blake Cooper — 1 of 16 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Kansas

Full comparison — all codes billed, vs. state median

16 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	26	30	1,770	$690	$1.3M
J2777	3	30	12,060	$30	$575.7K
J2778	10	20	860	$180	$297.6K
67028	19	40	1,170	$90	$111.4K
J3590	20	20	200	$100	$24.1K
92014	140	530	180	$70	$18.5K
99214	2,119	4,310	120	$70	$16.4K
92235	12	30	60	$90	$12.3K
99213	1,031	4,330	90	$50	$8.7K
92012	13	240	70	$60	$8.6K

Showing 1–10 of 16

Related Providers

Other providers that share a Tax Identification Number (TIN) with Blake Cooper, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
David Dyer	KS	Ophthalmology Physician	$7.5M	$0
Bassam Mattar	KS	Hematology & Oncology Physician	$7.2M	$0
Pavan Reddy	KS	Hematology & Oncology Physician	$6.7M	$0
Jeremy Deutsch	KS	Hematology & Oncology Physician	$5.7M	$0
Thomas Finley	OK	Ophthalmology Physician	$4.8M	$0
Daniel Feiler	KS	Ophthalmology Physician	$4.8M	$0
Travis Koeneke	KS	Hematology & Oncology Physician	$4.4M	$0
Christopher Dakhil	KS	Hematology & Oncology Physician	$4.4M	$0
Stephen Wiles	MO	Ophthalmology Physician	$4.4M	$0
Shaker Dakhil	KS	Hematology & Oncology Physician	$4.4M	$0

Nearby Providers

Other providers in the same ZIP code as Blake Cooper, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Bethesda Lutheran Communities	KS	Mental Illness Intermediate Care Facility	$0	$17.6M
Cherub Medical Supply, LLC	KS	Durable Medical Equipment & Medical Supplies	$0	$6.3M
Mawd Pathology Group Inc	KS	Anatomic Pathology & Clinical Pathology Physician	$660	$5.9M
Gregory Fox	KS	Ophthalmology Physician	$4M	$0
Ravi Singh	KS	Ophthalmology Physician	$3.9M	$0
Cpf Senior Living - Lenexa LLC	KS	Assisted Living Facility	$0	$3.8M
Beatty Suiter	KS	Ophthalmology Physician	$3.5M	$0
Ryan Christensen	KS	Ophthalmology Physician	$3.3M	$0
180 Medical, Inc.	KS	Durable Medical Equipment & Medical Supplies	$0	$2.7M
Midwest Division-oprmc LLC	KS	General Acute Care Hospital	$0	$2.6M

Blake Cooper — Billing Profile & Reimbursement Data

Sign up for Blake Cooper — Billing Profile & Reimbursement Data policy alerts

Blake Cooper — Billing Profile & Reimbursement Data

Sign up for Blake Cooper — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References